Skip to main content
. Author manuscript; available in PMC: 2019 Sep 23.
Published in final edited form as: Curr Hypertens Rep. 2019 Apr 25;21(6):45. doi: 10.1007/s11906-019-0950-y

Fig. 3.

Fig. 3

Plot of competing outcomes by RVEDV/LVEDV ratio. Reprinted without changes from SAGE Publishing, Benza et al., Bosentan-based, treat-to-target therapy in patients with pulmonary arterial hypertension: results from the COMPASS-3 study, Pulmonary Circulation, Vol 8, Issue 1, DOI: https://doi.org/10.1177/2045893217741480, under the Creative Commons open access license agreement (CC BY 4.0) [40]